| Total(N = 446) | Alive (N = 356) | Dead(N = 90) |
---|---|---|---|
Sex | |||
 Male | 213/446 (48%) | 161/356 (45%) | 52/90 (58%) |
 female | 233/446 (52%) | 195/356 (55%) | 38/90 (42%) |
Age (years) | 55/446 (42–66) | 50 (40–61) | 69 (62–78) |
 >60 | 179/446 (40%) | 104/356 (29%) | 75/90 (83%) |
Oxygen therapy | |||
 HFNC,NMV | 394/446 (88%) | 354/356 (99%) | 40/90 (44%) |
 IMV | 52/446 (12%) | 2/356 (1%) | 50/90 (56%) |
 Diabetes | 84/446 (19%) | 57/356 (16%) | 27/90 (30%) |
 Hypertension | 104/446 (23%) | 73/356 (21%) | 31/90 (34%) |
 Coronary heart disease | 35/446 (7.8%) | 22/356 (6.18%) | 13/90 (14.44%) |
Hospital length of stay (days) | 10 (8–14) | 10 (8–13) | 9 (5–12) |
White blood cell count (×109per L) | 5.50 (4.10–7.62) | 5.18 (3.95–7.05) | 7.56 (5.34–10.95) |
 <4 | 105/446 (23%) | 92/356 (26%) | 13/90 (14%) |
 4–10 | 289/446 (65%) | 239/356 (67%) | 50/90 (56%) |
 >10 | 52/446 (12%) | 25/356 (7%) | 27/90 (30%) |
Lymphocytes (×109per L) | 1.01 (0.68–1.41) | 1.12 (0.77–1.58) | 0.66 (0.44–0.89) |
 <1 | 218/446 (49%) | 145/356 (41%) | 73/90 (81%) |
  ≥ 1 | 228/446 (51%) | 211/356 (59%) | 17/90 (19%) |
Lymphocyte percentage (%) | 16.7 (3.95–27.60) | 20.75 (6.83–29.80) | 5.10 (0.31–11.50) |
 <20 | 253/446 (57%) | 173/356 (49%) | 80/90 (89%) |
  ≥ 20 | 193/446 (43%) | 183/356 (51%) | 10/90 (11%) |
 ALT (U/L) | 25 (16–42) | 24 (16–40) | 26 (16–50) |
 >40 | 121/446 (27%) | 84/356 (24%) | 37/90 (41%) |
 AST (U/L) | 27 (19–40) | 25 (18–37) | 26 (16–50) |
 >40 | 111/446 (25%) | 65/356 (18%) | 46/90 (51%) |
 BUN (mmol/L) | 4.5 (3.5–6.0) | 4.2 (3.3–5.5) | 6.97 (4.8–10.1) |
 >9.5 | 32/446 (7%) | 7/356 (2%) | 25/90 (28%) |
Creatinine, (μmol/L) | 63.7 (52.1–80.0) | 4.2 (3.3–5.5) | 73.1 (56.1–99.4) |
 >104 | 30/446 (7%) | 12/356 (3%) | 18/90 (20%) |
UA (μmol/L) | 245 (187–305) | 247 (194–315 | 242.00 (153–293) |
Glucose (mmol/L) | 5.8 (4.9–7.3) | 5.6 (4.9–6.7) | 7.2 (5.9–9.7) |
 >6.1 | 200/446 (45%) | 136/356 (38%) | 64/90 (71%) |
 3.9–6.1 | 235/446 (53%) | 210/356 (59%) | 25/90 (28%) |
 <3.9 | 11/446 (2%) | 10/356 (3%) | 1/90 (1%) |
Triglyceride (mmol/L) | 1.3 (1.0–1.7) | 1.3 (1.0–1.7) | 1.3 (1.1–1.6) |
Cholesterol (mmol/L) | 3.9 (3.4–4.4) | 3.9 (3.4–4.5) | 3.8 (3.2–4.3) |
High-sensitivity cardiac troponin I (ng/mL) | 0.006 (0.02–0.18) | 0.006 (0.002–0.008) | 0.02 (0.007–0.038) |
IL-6 (pg/mL) | 9.5 (6.1–22.0) | 7.8 (5.7–15.5) | 12.1 (8.9–25.4) |
Procalcitonin (ng/mL) | 0.05 (0.05–0.13) | 0.05 (0.04–0.09) | 0.14 (0.06–0.34) |
C-reactive protein (mg/L) | 26.8 (5.0–78.5) | 18.2 (5.0–49.0) | 84.3 (28.8–155.5) |
 >10 | 256/380 (67%) | 178/300 (59%) | 78/80 (98%) |